Clinical Trial Update: LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC [Phase 3]

View source ↗

Summary

LUNAR-2 is a Phase 3 trial evaluating Tumor Treating Fields (TTFields) with pembrolizumab and platinum-based chemotherapy for metastatic non-small cell lung can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)
• Platinum-based chemotherapy (platinum-based chemotherapy)
• Tumor Treating Fields (TTFields)

Snippet

Sponsor: NovoCure GmbH | Conditions: Metastatic Non-small Cell Lung Cancer | Phase 3 | Status: RECRUITING